Skip to content

Comparison of the use of Mitomycin C and Triamcinolone in the management of esophageal strictures in children which are refractory to standard management

Randomized â?? controlled trial of Mitomycin C vs. Triamcinolone in the management of refractory esophageal strictures in children

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/01/017262
Enrollment
90
Registered
2019-01-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K23- Disorders of esophagus in diseasesclassified elsewhere

Interventions

Intervention1: Mitomycin C: Cotton pledgets soaked in a solution (0.5 mg/mL) of mytomycin-C will be applied endoscopically directly onto the mucosa post dilation. Two pledgets will be applied for 30 s

Sponsors

Rishi Bolia
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All children ( - Refractory strictures will be defined as those in which it is not possible to relieve the anatomic restriction successfully up to a diameter of 14 mm (12.8 mm. in five sessions at 2-3 weekly intervals, due to cicatricial luminal compromise or fibrosis; - Recurrent strictures will be defined as those in which it is not possible to maintain a satisfactory luminal diameter for 4 wk once the target diameter of 14 mm (12.8 mm < 5 years ) has been achieved

Exclusion criteria

Exclusion criteria: - All patients who have received Mitomycin C or triamcinolone in the past. - Achalasia cardia - Patients with a history of iatrogenic perforation while undergoing dilataion - Patients / guardian refusal to give consent / assent.

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of Triamcinolone vs. Mitomycin â?? C application vs. standard management in terms of 1. Number of sessions of dilatations needed to achieve the target esophageal lumen diameter 2. Number of sessions of dilatations needed for alleviation of dysphagia 3. Number of patients having a recurrence of symptomsTimepoint: Both triamcinolone or Mitomycin C will be used for a maximum of 4 consecutive sessions. After each dilation, patients will remain under observation for at least 4 h. A repeat session of dilatation will be performed after 2-3 weeks.

Secondary

MeasureTime frame
noneTimepoint: N/A

Countries

India

Contacts

Public ContactRishi Kumar Bolia

Postgraduate Institute of Medical Education and Research (PGIMER)

rishibolia@yahoo.co.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026